» Articles » PMID: 38005889

Features of Tat Protein in HIV-1 Sub-Subtype A6 Variants Circulating in the Moscow Region, Russia

Abstract

Tat, the trans-activator of transcription, is a multifunctional HIV-1 protein that can induce chronic inflammation and the development of somatic diseases in HIV-infected patients. Natural polymorphisms in Tat can impact the propagation of the inflammatory signal. Currently, Tat is considered an object for creating new therapeutic agents. Therefore, the identification of Tat protein features in various HIV-1 variants is a relevant task. The purpose of the study was to characterize the genetic variations of Tat-A6 in virus variants circulating in the Moscow Region. The authors analyzed 252 clinical samples from people living with HIV (PLWH) with different stages of HIV infection. Nested PCR for two fragments (, ) with subsequent sequencing, subtyping, and statistical analysis was conducted. The authors received 252 sequences for and 189 for HIV-1 sub-subtype A6 was identified in 250 samples. The received results indicated the features of Tat1-A6 in variants of viruses circulating in the Moscow Region. In PLWH with different stages of HIV infection, C31S in Tat1-A6 was detected with different occurrence rates. It was demonstrated that Tat2-A6, instead of a functional significant RGD motif, had a QRD motif. Herewith, G79R in Tat2-A6 was defined as characteristic amino acid substitution for sub-subtype A6. Tat2-A6 in variants of viruses circulating in the Moscow Region demonstrated high conservatism.

Citing Articles

Rev Protein Diversity in HIV-1 Group M Clades.

Lebedev A, Kim K, Ozhmegova E, Antonova A, Kazennova E, Tumanov A Viruses. 2024; 16(5).

PMID: 38793640 PMC: 11125641. DOI: 10.3390/v16050759.

References
1.
Rao V, Neogi U, Talboom J, Padilla L, Rahman M, Fritz-French C . Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology. 2013; 10:61. PMC: 3686704. DOI: 10.1186/1742-4690-10-61. View

2.
Lapovok I, Lopatukhin A, Kireev D, Kazennova E, Lebedev A, Bobkova M . [Molecular epidemiological analysis of HIV-1 variants circulating in Russia in 1987-2015]. Ter Arkh. 2017; 89(11):44-49. DOI: 10.17116/terarkh2017891144-49. View

3.
Letunic I, Bork P . Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 2016; 44(W1):W242-5. PMC: 4987883. DOI: 10.1093/nar/gkw290. View

4.
Mediouni S, Chinthalapudi K, Ekka M, Usui I, Jablonski J, Clementz M . Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat. mBio. 2019; 10(1). PMC: 6368365. DOI: 10.1128/mBio.02662-18. View

5.
Jin H, Li D, Lin M, Li L, Harrich D . Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure. Viruses. 2020; 12(4). PMC: 7232260. DOI: 10.3390/v12040415. View